[alephnerd]

> manufacturer may have intentionally chosen the US since they could not anticipate losing the lottery and being properly tested

In an EU vs US showdown, a manufacturer will sell the "inferior" product to US, but US and EU product safety regulations are miles beyond other large markets (China, India, Brazil, Russia, ASEAN, etc).

Manufacturers will absolutely create different SKUs of the exact same brand for different export markets. Try out P&G products in Thailand versus the US for example. Or the Indian Cough Syrup scandal where Indian companies exported cough syrups that wouldn't pass Indian regulatory muster to Africa, Central Asia, and poorer parts of India

[potatopatch]

Any level of random sampling is a serious concern for a conglomerate like P&G with both many products and high volume. Negasmart may be able to sell for years at a substantial volume for them, at a considerably higher price compared to BRICS, before their first finding. I would like to see evidence from the FDA that they aren't just lucky on this one detection, (if it even was detected by them before doctors/parents reports.)

[Turing_Machine]

It happens far more often than you'd think, and it rarely makes the news.

We're talking hundreds of times every month.

https://www.accessdata.fda.gov/scripts/ImportRefusals/index....

Not all of these are refused for being dangerous, of course. Some just have inaccurate labels or suchlike. But still hundreds of times each and every month.